DOI: 10.1055/s-00000017

Experimental and Clinical Endocrinology & Diabetes

Ausgabe 03 · Volume 112 · März 2004 DOI: 10.1055/s-002-3258

Article

  • 123
    Breidert, M.; Zimmermann, T. F.; Schneider, R.; Ehninger, G.; Brabant, G.:

    Ghrelin/Leptin-Imbalance in Patients with Primary Biliary Cirrhosis

  • 127
    Kumbasar, B.; Taylan, I.; Kazancioglu, R.; Agan, M.; Yenigun, M.; Sar, F.:

    Myelofibrosis Secondary to Hyperparathyroidism

  • 131
    Carpino, A.; Tarantino, P.; Rago, V.; De Sanctis, V.; Siciliano, L.:

    Antioxidant Capacity in Seminal Plasma of Transfusion-Dependent β-Thalassemic Patients

  • 135
    Rudofsky, G.; Isermann, B.; Schilling, T.; Schiekofer, S.; Andrassy, M.; Schneider, J. G.; Morcos, M.; Humpert, P. M.; Sayed, A. A. R.; Witte, S.; Renn, W.; Pfohl, M.; Hamann, A.; Nosikov, V.; Schleicher, E.; Häring, H.-U.; Ritz, E.; Nawroth, P. P.; Bierhaus, A.:

    A 63bp Deletion in the Promoter of RAGE Correlates with a Decreased Risk for Nephropathy in Patients with Type 2 Diabetes

  • 142
    Verspohl, E. J.; Hagemann, J.; Lempka, M.:

    Vascular Smooth Muscle Cells (VSMC) Proliferation of Streptozotocin-Diabetic Animals Induced by Diadenosine Polyphosphates

  • 148
    Lindner, O.; Klein, E.; Franzke, K.; Petzoldt, R.; Burchert, W.:

    Scintigraphic Monitoring of Catheter-Port Systems in Type I Diabetics with Continuous Insulin Therapy